Geode Capital Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
+826,333
| New | +$1.22M | ﹤0.01% | 3271 |
|
|
2024
Q2 | – | Sell |
-754,110
| Closed | -$950K | – | 4613 |
|
|
2024
Q1 | $950K | Buy |
754,110
+29,535
| +4% | +$37.2K | ﹤0.01% | 3383 |
|
|
2023
Q4 | $1.29M | Buy |
724,575
+24,364
| +3% | +$43.4K | ﹤0.01% | 3245 |
|
|
2023
Q3 | $1.16M | Buy |
700,211
+147,840
| +27% | +$245K | ﹤0.01% | 3262 |
|
|
2023
Q2 | $1.1M | Buy |
+552,371
| New | +$1.1M | ﹤0.01% | 3308 |
|